Type 1 diabetes is caused by the body's own immune system damaging the cells in the pancreas that make insulin. Researchers at Cardiff and Swansea Universities would like to develop a treatment that can slow this process down, by targeting the immune cells causing the damage.
They'd like people aged 12-18 years who have been diagnosed with Type 1 diabetes within the last 100 days to take part in their study, testing a new medicine called Ustekinumab. When first diagnosed with Type 1 diabetes, most people still have 10-20% of their insulin-producing cells still working. The researchers believe this new medicine could help the pancreas make insulin for longer.
Taking part involves eight visits over 12 months to receive the drug (or a placebo (dummy) drug), and blood and urine tests. As a thank you, study volunteers will receive a £10 gift voucher for each visit and £30 gift voucher for the final, eighth visit.